Does the lunasin peptide plus chemo drug block colon cancer spread to liver?

A new study reports a promising new weapon in treating metastatic colon cancer, particularly in patients who have developed resistance to chemotherapy. The research finds that the soy peptide lunasin binds to a specific receptor in highly metastatic colon cancer cells, preventing them from attaching to the liver.